Nanoparticles Delivery of 'Suicide DNA' Kills Prostate Tumors

Using nanoparticles developed by members of the Alliance for Nanotechnology in Cancer, a team of investigators at the Lankenau Institute for Medical Research, in Philadelphia, has developed a DNA-based therapeutic agent that has the potential to treat both enlarged prostates and localized prostate tumors. When tested in mice, this new agent specifically targeted prostate tissue, producing no toxic effects in surrounding tissues.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news99066029.html">Nanoparticles Delivery of 'Suicide DNA' Kills Prostate Tumors</a></p> <p>Using nanoparticles developed by members of the Alliance for Nanotechnology in Cancer, a team of investigators at the Lankenau Institute for Medical Research, in Philadelphia, has developed a DNA-based therapeutic agent that has the potential to treat both enlarged prostates and localized prostate tumors. When tested in mice, this new agent specifically targeted prostate tissue, producing no toxic effects in surrounding tissues.</p>